Trial Profile
An Open-label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Apr 2018
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Autistic disorder
- Focus Adverse reactions
- Sponsors Forest Laboratories
- 09 Dec 2013 New trial record